Search

everythinglearnresearchcommunity

for

Search:↓

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

SET7/9 enzyme affects cell growth and diseases like cancer, diabetes, and obesity.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Chronic inflammation can cause cancer by making stem cells divide and mutate.

Hinokiflavone may help treat cancers and other health issues.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Juniperus morrisonicola wood essential oil has strong anti-inflammatory and antifungal properties.

Bee venom shows promise for treating cancer, infections, inflammation, and hair loss.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Finasteride use in male rats may harm their male offspring's liver function.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

Bhrungraj extract showed strong potential to fight liver cancer cells.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

UVB exposure increases appetite by activating p53 in skin cells.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

TGM3 is important for skin and hair structure and may help diagnose cancer.

Engineered extracellular vesicles could improve CRISPR/Cas delivery, making gene editing safer and more effective.

The new drug delivery system effectively targets lung cancer cells.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.